|
業務類別
|
Biotechnology |
|
業務概覽
|
Karyopharm Therapeutics Inc is a commercial-stage pharmaceutical company focused on novel cancer therapies and dedicated to the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. The company conducts research focused on intracellular communication between the nucleus and cytoplasm and has developed small-molecule compounds that inhibit exportin 1 (XPO1), a nuclear export protein. It is focused on marketing XPOVIO (selinexor). |
| 公司地址
| 85 Wells Avenue, 2nd Floor, Newton, MA, USA, 02459 |
| 電話號碼
| +1 617 658-0600 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.karyopharm.com |
| 員工數量
| 228 |
| Mr. Richard Paulson, M.B.A. |
Director, President and Chief Executive Officer |
美元 770.00K |
13/04/2026 |
| Dr. Reshma Rangwala, M.D.,PhD |
Executive Vice President and Chief Medical Officer |
美元 567.74K |
13/02/2026 |
| Mr. Michael Mano, J.D. |
Executive Vice President, Chief Legal Officer and Secretary |
-- |
13/02/2026 |
| Ms. Lori Macomber, C.P.A. |
Executive Vice President, Chief Financial Officer and Treasurer |
-- |
13/02/2026 |
| Ms. Sohanya Roshan Cheng, M.B.A. |
Executive Vice President and Chief Commercial Officer |
-- |
13/02/2026 |
| Mr. Stuart Poulton |
Executive Vice President and Chief Development Officer |
美元 500.14K |
13/02/2026 |
| Ms. Kristin Abate |
Vice President, Chief Accounting Officer, and Assistant Treasurer |
-- |
13/02/2026 |
|
|
| Mr. Barry E. Greene |
Lead Independent Director |
13/04/2026 |
| Mr. Chen Schor, M.B.A. |
Independent Director |
13/04/2026 |
| Mr. Garen G. Bohlin |
Independent Director |
13/04/2026 |
| Dr. Deepika Rachel Pakianathan |
Independent Director |
13/04/2026 |
| Mr. Richard Paulson, M.B.A. |
Director, President and Chief Executive Officer |
13/04/2026 |
| Ms. Christy J. Oliger |
Independent Director |
13/04/2026 |
| Dr. Zhen Su |
Independent Director |
13/04/2026 |
|
|
|
|
